Endocrine treatment of prostate cancer: standard treatment and new perspectives
Boccardo, F.; Pace, M.
In Vivo 7(5): 423-424
1993
ISSN/ISBN: 0258-851X PMID: 8110985 Document Number: 409150
The hormonal treatment of advanced prostate cancer is still a controversial matter although new drugs are being tested in clinical trials all over the world. The results of these trials are the subject of dispute for reasons related to the natural history and clinical evolution of prostate cancer.
Document emailed within 1 workday
Related Documents
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Kamoto, T. 2002: Management of side effects of endocrine treatment for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 299-303
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Glybochko, P.V.; Alyaev, Y.G.; Rapoport, L.M.; Enikeev, D.V.; Okhunov, Z.; Netsch, C.; Spivak, L.G.; Taratkin, M.S. 2018: Endoscopic enucleation of the prostate: a short term trend or a new treatment standard? Urologiia 2: 130-133
Habib, F.K.; Ross, M.; Bayne, C.W. 1999: Factors controlling the expression of 5alpha-reductase in human prostate: A possible new approach for the treatment of prostate cancer European Urology 35(5-6): 439-442
Arai, Y.; Matsuda, T.; Kamoto, T.; Hashimura, T.; Oishi, K.; Takeuchi, H.; Yoshida, O. 1992: Treatment of endocrine-resistant stage D carcinoma of the prostate with a cisplatin derivative (DWA2114R): a pilot study Hinyokika Kiyo. Acta Urologica Japonica 38(8): 897-902
Rébillard, X.; Davin, J-Louis.; Soulié, M. 2003: Treatment by HIFU of prostate cancer: survey of literature and treatment indications Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(6): 1428-1456
Fuchsjäger, M.; Akin, O.; Shukla-Dave, A.; Pucar, D.; Hricak, H. 2009: The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer Clinical Advances in Hematology and Oncology: H&o 7(3): 193-202
Eiken, P.A.; Langdahl, B.L.; Eiken, F.L.; Walter, S.; Poulsen, M.Hvid.; Abrahamsen, B. 2011: Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer Ugeskrift for Laeger 173(48): 3093-3096
Jager, P.L.; Mensink, H.J.; van den Bergh, A.C.; Piers, D.A. 1999: A strontium-89 injection: a simple treatment of painful bone metastases in patients with prostate cancer unresponsive to hormonal treatment Nederlands Tijdschrift Voor Geneeskunde 143(19): 969-973
Wilding, G. 1995: Endocrine control of prostate cancer Cancer Surveys 23: 43-62
Falcone, T.; Falutz, G.; Tolis, G. 1982: LH-RH-endocrine manipulation in cancer of the prostate Biomedicine and PharmacoTherapy 36(8-9): 344-348
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352
Usami, M. 1998: Endocrine therapy for prostate cancer in the future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(6): 817-822
Stred, S.E. 2015: Endocrine Consequences of Treatment for Childhood Cancer Adolescent Medicine: State of the Art Reviews 26(2): 448-459
Cottu, P. 2013: Breast cancer adjuvant endocrine treatment La Revue du Praticien 63(10): 1404-1407
Takada, M.; Ishiguro, H.; Toi, M. 2008: Treatment for breast cancer and endocrine neoplasm Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(13): 2344-2350
Teodorovich, O.V.; Shatokhin, M.N.; Naryshkin, S.A.; Abdullayev, M.I.; Krasnov, A.V.; Borisenko, G.G.; Zhurbenko, A.A. 2019: Focal laser coagulation in the treatment of a patient with kidney cancer and prostate cancer Urologiia 2: 55-58
Imaida, K.; Shirai, T. 2000: Endocrine disrupting chemicals and carcinogenesis--breast, testis and prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58(12): 2527-2532